The neuronal microtubule-associated protein tau is a substrate for caspase-3 and an effector of apoptosis

Journal of Neurochemistry

Volumn 75, Issue 2, 2000, Pages 624-633

  Fasulo, Luisa ^a   Ugolini, Gabriele ^a   Visintin, Michela ^a   Bradbury, Andrew ^a   Brancolini, Claudio ^b   Verzillo, Vittorio ^a   Novak, Michal ^a,c   Cattaneo, Antonino ^a  

^a SISSA   (Italy)

^b Lab Naz Consorzio I   (Italy)

^c INSTITUTE OF NEUROIMMUNOLOGY   (Slovakia)

Author keywords

Apoptosis; Caspase 3; Microtubule; Tau

Indexed keywords

CASPASE 3; TAU PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; DEGENERATIVE DISEASE; ENZYME SUBSTRATE COMPLEX; MICROTUBULE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CASPASE 3; CASPASES; COS CELLS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NEUROBLASTOMA; NEURONS; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY; TAU PROTEINS; TERATOCARCINOMA; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0033928035     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0750624.x     Document Type: Article

References (48)

1. Anderson A. J., Su J. H., and Cotman C. W. (1996) DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J. Neurosci. 16, 1710-1719.
2. Barnes N. Y., Li L., Yoshikawa K., Schwartz L. M., Oppenheim R. W., and Milligan C. E. (1998) Increased production of amyloid precursor protein provides a substrate for caspase-3 in dying motoneurons. J. Neurosci. 18, 5869-5880.
3. Bednarski E. and Lynch G. (1996) Cytosolic proteolysis of τ by cathepsin D in hippocampus following suppression of cathepsins B and L. J. Neurochem. 67, 1846-1855.
4. Brancolini C, Benedetti M., and Schneider C. (1995) Microfilament reorganization during apoptosis: the role of Gas2, a possible substrate for ICE-like proteases. EMBO J. 14, 5179-5190.
5. Brancolini C., Lazarevich D., Rodriguez J., and Schneider C. (1997) Dismantling cell-cell contacts during apoptosis is coupled to caspase-dependent proteolytic cleavage of β-catenin. J. Cell Biol. 139, 759-771.
6. Canu N., Dus L., Barbato C., Ciotti M. T., Brancolini C., Rinaldi A. M., Novak M., Cattaneo A., Bradbury A., and Calissano P. (1998) Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis. J. Neurosci. 18, 7061-7074.
7. Esposito G., Viglino P., Novak M., and Cattaneo A. (2000) The solution structure of a C-terminal peptide of human tau. J. Pept. Sci. (in press).
8. Fasulo L., Ovecka M., Kabat J., Bradbury A., Novak M., and Cattaneo A. (1996) Overexpression of Alzheimer's PHF core tau fragments: implications for the tau truncation hypothesis. Alzheimers Res. 2, 195-200.
9. Fasulo L., Visintin M., Novak M., and Cattaneo A. (1998) Tau truncation in Alzheimer's disease: expression of a fragment encompassing PHF core tau induces apoptosis in COS cells. Alzheimer's Rep. 1, 25-32.
10. Geng Y. J., Azuma T., Tang J. X., Hartwig J. H., Muszynski M., Wu Q., Libby P., and Kwiatkowski D. J. (1998) Caspase-3-induced gelsolin fragmentation contributes to actin cytoskeletal collapse, nucleolysis, and apoptosis of vascular smooth muscle cells exposed to proinflammatory cytokines. Eur. J. Cell. Biol. 77, 294-302.
11. Gervais F. G., Xu D., Robertson G. S., Vaillancourt J. P., Zhu Y., Huang J., LeBlanc A., Smith D., Rigby M., Shearman M. S., Clarke E. E., Zheng H., Van Der Ploeg L. H., Ruffolo S. C., Thornberry N. A., Xanthoudakis S., Zamboni R. J., Roy S., and Nicholson D. W. (1999) Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic Aβ peptide formation. Cell 97, 395-406.
12. Goedert M., Spillantini M. G., Cairns N. J., and Crowther R. A. (1992) Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 8, 159-168.
13. Goldberg Y. P., Nicholson D. W., Rasper D. M., Kalchman M. A., Koide H. B., Graham R. K., Bromm M., Kazemi-Esfarjani P., Thornberry N. A., Vaillancourt J. P., and Hayden M. R. (1996) Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nat. Genet. 13, 442-449.
14. Ibrado A. M., Huang Y., Fang G., and Bhalla K. (1996) Bcl-xL overexpression inhibits Taxol-induced Yama protease activity and apoptosis. Cell Growth Differ. 71, 1087-1094.
15. Igarashi S., Koide R., Shimohata T., Yamada M., Hayashi Y., Takano H., Date H., Oyake M., Sato T., Sato A., Egawa S., Ikeuchi T., Tanaka H., Nakano R., Tanaka K., Hozumi I., Inuzuka T., Takahashi H., and Tsuji S. (1998) Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nat. Genet. 18, 111-117.
16. Janicke R. U., Ng P., Sprengart M. L., and Porter A. G. (1998) Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J. Biol. Chem. 273, 15540-15545.
17. Johnson G. V., Seubert P., Cox T. M., Motter R., Brown J. P., and Galasko D. (1997) The T protein in human cerebrospinal fluid in Alzheimer's disease consists of proteolytically derived fragments. J. Neurochem. 68, 430-433.
18. Kayalar C., Ord T., Testa M. P., Zhong L. T., and Bredesen D. E. (1996) Cleavage of actin by interleukin 1 beta-converting enzyme to reverse DNase I inhibition. Proc. Natl. Acad. Sci. USA 93, 2234-2238.
19. Kim T. W., Pettingell W. H., Jung Y. K., Kovacs D. M., and Tanzi R. E. (1997) Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science 277, 373-376.
20. Kothakota S., Azuma T., Reinhard C, Klippel A., Tang J., Chu K., McGarry T. J., Kirschner M. W., Koths K., Kwiatkowski D. J., and Williams L. T. (1997) Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 278, 294-298.
21. LeFerla F. M., Tinkle B. T., Bieberich C. J., Haudenschild C. C., and Jay G. (1995) The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nat. Genet. 9, 21-30.
22. Loetscher H., Deuschle U., Brockhaus M., Reinhardt D., Nelboeck P., Mous J., Grunberg J., Haass C., and Jacobsen H. (1997) Presenilins are processed by caspase-type proteases. J. Biol. Chem. 272, 20655-20659.
23. Loo D. T., Copani A., Pike C. J., Whittemore E. R., Walencewicz A. J., and Cotman C. W. (1993) Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA 90, 7951-7955.
24. Mandelkow E. M. and Mandelkow E. (1998) Tau in Alzheimer's disease. Trends Cell. Biol. 8, 425-427.
25. Martin S. J., O'Brien G. A., Nishioka W. K., McGahon A. J., Mahboubi A., Saido T. C., and Green D. R. (1995) Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J. Biol. Chem. 270, 6425-6428.
26. Mashima T., Naito M., Noguchi K., Miller D. K., Nicholson D. W., and Tsuruo T. (1997) Actin cleavage by CPP-32/apopain during the development of apoptosis. Oncogene 14, 1007-1012.
27. Mattson M. P. and Guo Q. (1997) Cell and molecular neurobiology of presenilins: a role for the endoplasmic reticulum in the pathogenesis of Alzheimer's disease? J. Neurosci. Res. 50, 505-513.
28. Mercken M., Grynspan F., and Nixon R. A. (1995) Differential sensitivity to proteolysis by brain calpain of adult human tau, fetal human tau and PHF-tau. FEBS Lett. 368, 10-14.
29. Nasir J., Goldberg Y. P., and Hayden M. R. (1996) Huntington disease: new insights into the relationship between CAG expansion and disease. Hum. Mol. Genet. 5, 1431-1435.
30. Novak M., Jakes R., Edwards P. C., Milstein C., and Wischik C. M. (1991) Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.51. Proc. Natl. Acad. Sci. USA 88, 5837-5841.
31. Novak M., Kabat J., and Wischik C. M. (1993) Molecular characterisation of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. EMBO J. 12, 365-370.
32. Ona V. O., Li M., Vonsattel J. P., Andrews L. J., Khan S. Q., Chung W. M., Frey A. S., Menon A. S., Li X. J., Stieg P. E., Yuan J., Penney J. B., Young A. B., Cha J. H., and Friedlander R. M. (1999) Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature 399, 263-267.
33. Portera-Cailliau C., Hedreen J. C., Price D. L., and Koliatsos V. E. (1995) Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J. Neurosci. 15, 3775-3787.
34. Ruben G. C., Iqbal K., Grundke-Iqbal I., Wisniewski H. M., Ciardelli T. L., and Johnson J. E. Jr. (1991) The microtubule-associated protein tau forms a triple stranded left-hand helical polymer. J. Biol. Chem. 266, 22019-22027.
35. Salvesen G. S. and Dixit V. M. (1997) Caspases: intracellular signalling by proteolysis. Cell 91, 443-446.
36. Sanchez I., Xu C. J., Juo P., Kakizaka A., Blenis J., and Yuan J. (1999) Caspase-8 is required for cell death induced by expanded polyglutamine repeats. Neuron 22, 623-633.
37. Sanger F., Nicklen S., and Coulson A. R. (1977) DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463-5467.
38. Schweers O., Mandelkow E. M., Biernat J., and Mandelkow E. (1995) Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments. Proc. Natl. Acad. Sci. USA 92, 8463-8467.
39. Spillantini M. G. and Goedert M. (1998) Tau protein pathology in neurodegenerative diseases. Trends Neurosci. 21, 428-433.
40. Tewari M., Quan L. T., O'Rourke K., Desnoyers S., Zeng Z., Beidler D. R., Poirier G. G., Salvesen G. S., and Dixit V. M. (1995) Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81, 801-809.
41. Ugolini G., Cattaneo A., and Novak M. (1997) Co-localisation of truncated tau and DNA fragmentation in Alzheimer's disease neurones. Neuroreport 8, 3709-3712.
42. Van de Craen M., De Jonghe C., Van den Brande I., Declercq W., Van Gassen G., Van Criekinge W., Vanderhoeven I., Fiers W., Van Broeckhoven C., Hendriks L., and Vandenabeele P. (1999) Identification of caspases that cleave presenilin-1 and presenilin-2. Five presenilin-1 (PS1) mutations do not alter the sensitivity of PS1 to caspases. FEBS Lett. 445, 149-154.
43. Weidemann A., Paliga K., Durrwang U., Reinhard F. B., Schuckert O., Evin G., and Masters C. L. (1999) Proteolytic processing of the Alzheimer's disease amyloid precursor protein within its cytoplasmic domain by caspase-like proteases. J. Biol. Chem. 274, 5823-5829.
44. Wellington C. L., Ellerby L. M., Hackam A. S., Margolis R. L., Trifiro M. A., Singaraja R., McCutcheon K., Salvesen G. S., Propp S. S., Bromm M., Rowland K. J., Zhang T., Rasper D., Roy S., Thornberry N., Pinsky L., Kakizuka A., Ross C. A., Nicholson D. W., Bredesen D. E., and Hayden M. R. (1998) Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J. Biol. Chem. 273, 9158-9167.
45. Wischik C. M., Novak M., Thogersen H. C., Edwards P. C., Runswick M. J., Jakes R., Walker J. E., Milstein C., Roth M., and Klug A. (1988) Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc. Natl. Acad. Sci. USA 85, 4506-4510.
46. Yamatsuji T., Okamoto T., Takeda S., Murayama Y., Tanaka N., and Nishimoto I. (1996) Expression of V642 APP mutant causes cellular apoptosis as Alzheimer trait-linked phenotype. EMBO J. 15, 498-509.
47. Yankner B. A., Dawes L. R., Fisher S., Villa-Komaroff L., Oster-Granite M. L., and Neve R. L. (1989) Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 245, 417-420.
48. Yuan J. and Yankner B. A. (1999) Caspase activity sows the seeds of neuronal death. Nat. Cell. Biol. 1, E44-E45.